2-5A pentasodium solution (100 mM)
Based on 1 Customer Validation
2-5A pentasodium solution (100 mM) (2′,5′-ApApA pentasodium solution (100 mM)) is a 5'-triphosphorylated (2',5') oligoadenylate. When covalently linked to an antisense molecule complementary to the target sequence, 2-5A pentasodium solution (100 mM) activates RNase L, which subsequently degrades the target RNA bound to the 2-5A pentasodium solution (100 mM) chimera. 2-5A pentasodium solution (100 mM) can be used in research related to respiratory syncytial virus infection, colorectal adenocarcinoma and melanoma.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit: 90.0%
- Formel: C30H35N15Na5O25P5
- Molecular Weight:1275.50
-
Speicherung:
Solution, -20°C, 2 years
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Alle DNA/RNA Synthesis Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
|
RNASE L |
2-5A (1 μM; 4 h) pentasodium solution (100 mM) is imported by human HEK293T cells and BJ1 fibroblasts to activate RNase L-dependent IFN/ISG induction, while mouse MEFs, MC38 cells, BMDMs, human A549 cells, and THP-1 monocytes do not exhibit robust 2-5A pentasodium solution (100 mM) import activity[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:human HEK293T cells, human BJ1 fibroblasts, mouse MEFs, mouse MC38 cells, mouse bone-marrow-derived macrophages (BMDMs), human A549 cells, human THP-1 monocytes
-
Concentration:1 μM
-
Incubation Time:4 h
-
Result:Stimulated significant IFNB1 and CXCL10 mRNA expression in human HEK293T cells and BJ1 fibroblasts.
Abolished IFN/ISG response in RNase L-knockout HEK293T and BJ1 cells.
Failed to induce robust IFN/ISG response in mouse MEFs, MC38 cells, BMDMs, human A549 cells, and THP-1 monocytes.
Induced robust IFN/ISG expression in all tested cell lines when transfected with Lipofectamine.
2-5A (10 μg; peritumoral injection; once daily; 3 consecutive days) pentasodium solution (100 mM) complexed with lipofectamine significantly inhibits B16 melanoma tumor growth in wild-type C57BL/6J mice[3].
2-5A (10 μg; peritumoral injection; once daily; 3 consecutive days) pentasodium solution (100 mM) complexed with lipofectamine significantly inhibits sgRnasel MC38 colorectal carcinoma tumor growth in wild-type C57BL/6J mice[3].
2-5A (10 μg; peritumoral injection; once daily; 3 consecutive days) pentasodium solution (100 mM) complexed with lipofectamine does not inhibit MC38 colorectal carcinoma tumor growth in RnaseI−/− mice[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6J wild-type (6-8 weeks old, same sex, subcutaneous implantation of 5×105 WT MC38 cells)[3]
-
Dosage:10 μg (complexed with lipofectamine)
-
Administration:peritumoral injection; once daily; 3 consecutive days
-
Result:Significantly inhibited MC38 tumor growth compared to PBS, naked 2-5A (TEA), or lipofectamine alone.
Showed statistically significant difference in tumor volume between the lipofectamine+2-5A group and lipofectamine alone group (P=0.0142).
-
Animal Model:C57BL/6J wild-type (6-8 weeks old, same sex, subcutaneous implantation of 5×105 B16 cells)[3]
-
Dosage:10 μg (complexed with lipofectamine)
-
Administration:peritumoral injection; once daily; 3 consecutive days
-
Result:Significantly inhibited B16 melanoma tumor growth compared to lipofectamine alone (P=0.0185).
Chemical Information
-
Appearance Liquid
-
Molecular Weight 1275.50
-
Formel C30H35N15Na5O25P5
-
Color Colorless to light yellow
-
SMILES
NC1=NC=NC2=C1N=CN2[C@H]3[C@H](OP(OC[C@@H](O[C@H]([C@@H]4OP(OC[C@@H](O[C@H]([C@@H]5O)N6C=NC7=C6N=CN=C7N)[C@H]5O)(O[Na])=O)N8C=NC9=C8N=CN=C9N)[C@H]4O)(O[Na])=O)[C@H](O)[C@@H](COP(OP(OP(O)(O[Na])=O)(O[Na])=O)(O[Na])=O)O3
-
Synonyms
2′,5′-ApApA pentasodium; 2′,5′-trioligoadenylate pentasodium; 5'-O-Triphosphoryladenylyl-(2'→5')-adenylyl-(2'→5')-adenosine pentasodium
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Solution, -20°C, 2 years
Reinheit & Dokumentation
-
Data Sheet (284 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
Verweise
[1]. Barnard DL, et al. 2-5A-DNA conjugate inhibition of respiratory syncytial virus replication: effects of oligonucleotide structure modifications and RNA target site selection. Antiviral research. 1999 Apr;41(3):119-34. [Content Brief]
[2]. Wang S, et al. 2-5A is an immunotransmitter that fuels RNase L immunity. Immunity. 2025 Apr 08;58(4):770-772. [Content Brief]
[3]. Huai W, et al. OAS cross-activates RNase L intercellularly through cell-to-cell transfer of 2-5A to spread innate immunity. Immunity. 2025 Apr 08;58(4):797-810.e6. [Content Brief]
[4]. Kalinichenko EN, et al. 3'-Fluoro-3'-deoxy analogs of 2-5A 5'-monophosphate: binding to 2-5A-dependent endoribonuclease and susceptibility to (2'-5')phosphodiesterase degradation. Biochemical and biophysical research communications. 1990 Feb 28;167(1):20-6. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
2-5A pentasodium solution (100 mM) Related Classifications
HY-173189A Related Classifications
Powered by Bioz
- 2-5A pentasodium solution (100 mM)
- 2′,5′-ApApA pentasodium
- 2′,5′-trioligoadenylate pentasodium
- 5'-O-Triphosphoryladenylyl-(2'→5')-adenylyl-(2'→5')-adenosine pentasodium
- RSV
- DNA/RNA Synthesis
- RNase L
- Sendai virus
- HEK293T human embryonic kidney cells
- BJ1 human foreskin fibroblasts
- ENPP1
- MC38 cells
- melanoma
- vesicular stomatitis virus
- colorectal adenocarcinoma
- respiratory syncytial virus
- Inhibitor
- inhibitor
- inhibit